Invesco Ltd. Oncocyte Corp Transaction History

Invesco Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.86 - $1.53 $18,621 - $33,129	-21,653 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.15 - $2.25 $280 - $549	244 Added 1.14%	21,653 $32,000
Q4 2021 Feb 14, 2022	SELL	$2.04 - $3.59 $979 - $1,723	-480 Reduced 2.19%	21,409 $46,000
Q3 2021 Nov 15, 2021	BUY	$3.53 - $5.89 $10,717 - $17,882	3,036 Added 16.1%	21,889 $78,000
Q2 2021 Aug 17, 2021	SELL	$3.77 - $6.0 $54,947 - $87,450	-14,575 Reduced 43.6%	18,853 $108,000
Q1 2021 May 17, 2021	BUY	$2.39 - $6.5 $5,537 - $15,060	2,317 Added 7.45%	33,428 $173,000
Q4 2020 Feb 16, 2021	BUY	$1.38 - $2.63 $42,933 - $81,821	31,111 New	31,111 $74,000

411K

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $266M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.